A major obstacle to a better understanding of melatonin's role in breast cancer invasion and metastasis is the lack of a cell line that exhibits a strong invasive potential but that is also estrogen receptor-alpha (ERα)-positive and melatonin-responsive. The gene discussed is ESR1; the disease is breast carcinoma.